{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:40:26Z","timestamp":1775202026566,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This author is the CEO of the IPCRG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Respiratory diseases remain a significant cause of global morbidity and mortality and primary care plays a central role in their prevention, diagnosis and management. An e-Delphi process was employed to identify and prioritise the current respiratory research needs of primary care health professionals worldwide. One hundred and twelve community-based physicians, nurses and other healthcare professionals from 27 high-, middle- and low-income countries suggested 608 initial research questions, reduced after evidence review by 27 academic experts to 176 questions covering diagnosis, management, monitoring, self-management and prognosis of asthma, COPD and other respiratory conditions (including infections, lung cancer, tobacco control, sleep apnoea). Forty-nine questions reached 80% consensus for importance. Cross-cutting themes identified were: a need for more effective training of primary care clinicians; evidence and guidelines specifically relevant to primary care, adaption for local and low-resource settings; empowerment of patients to improve self-management; and the role of the multidisciplinary healthcare team.<\/jats:p>","DOI":"10.1038\/s41533-021-00266-4","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:03:34Z","timestamp":1643367814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prioritising primary care respiratory research needs: results from the 2020 International Primary Care Respiratory Group (IPCRG) global e-Delphi exercise"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0934-7954","authenticated-orcid":false,"given":"Arwa","family":"Abdel-Aal","sequence":"first","affiliation":[]},{"given":"Karin","family":"Lisspers","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0527-2254","authenticated-orcid":false,"given":"Si\u00e2n","family":"Williams","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-3945","authenticated-orcid":false,"given":"Peyman\u00e9","family":"Adab","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1798-3854","authenticated-orcid":false,"given":"Rachel","family":"Adams","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7868-9309","authenticated-orcid":false,"given":"Dhiraj","family":"Agarwal","sequence":"additional","affiliation":[]},{"given":"Amanda","family":"Barnard","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-3550","authenticated-orcid":false,"given":"Izolde","family":"Bouloukaki","sequence":"additional","affiliation":[]},{"given":"Job F. M.","family":"van Boven","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8607-9199","authenticated-orcid":false,"given":"Niels","family":"Chavannes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-8129","authenticated-orcid":false,"given":"Andrew P.","family":"Dickens","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-1016","authenticated-orcid":false,"given":"Frederik","family":"van Gemert","sequence":"additional","affiliation":[]},{"given":"Mercedes","family":"Escarrer","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0096-1413","authenticated-orcid":false,"given":"Shamil","family":"Haroon","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-3821","authenticated-orcid":false,"given":"Alex","family":"Kayongo","sequence":"additional","affiliation":[]},{"given":"Bruce","family":"Kirenga","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2760-0693","authenticated-orcid":false,"given":"Janwillem W. H.","family":"Kocks","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-023X","authenticated-orcid":false,"given":"Daniel","family":"Kotz","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Newby","sequence":"additional","affiliation":[]},{"given":"Cliodna","family":"McNulty","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1677-3529","authenticated-orcid":false,"given":"Esther","family":"Metting","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Moral","sequence":"additional","affiliation":[]},{"given":"Sophia","family":"Papadakis","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-8386","authenticated-orcid":false,"given":"Hilary","family":"Pinnock","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-9992","authenticated-orcid":false,"given":"David","family":"Price","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4115-7376","authenticated-orcid":false,"given":"Dermot","family":"Ryan","sequence":"additional","affiliation":[]},{"given":"Sally J.","family":"Singh","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6459-7908","authenticated-orcid":false,"given":"Jaime","family":"Correia de Sousa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-7326","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"St\u00e4llberg","sequence":"additional","affiliation":[]},{"given":"Stanley J.","family":"Szefler","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7454-6354","authenticated-orcid":false,"given":"Stephanie J. C.","family":"Taylor","sequence":"additional","affiliation":[]},{"given":"Ioanna","family":"Tsiligianni","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5947-3254","authenticated-orcid":false,"given":"Alice","family":"Turner","sequence":"additional","affiliation":[]},{"given":"David","family":"Weller","sequence":"additional","affiliation":[]},{"given":"Osman","family":"Yusuf","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4850-7746","authenticated-orcid":false,"given":"Aizhamal K.","family":"Tabyshova","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0747-6883","authenticated-orcid":false,"given":"Rachel E.","family":"Jordan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"266_CR1","doi-asserted-by":"publisher","unstructured":"Soriano, J. B. et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30105-3 (2020).","DOI":"10.1016\/S2213-2600(20)30105-3"},{"key":"266_CR2","doi-asserted-by":"publisher","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(20)31404-5 (2020).","DOI":"10.1016\/S0140-6736(20)31404-5"},{"key":"266_CR3","doi-asserted-by":"publisher","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9 (2020).","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"266_CR4","unstructured":"European Respiratory Society. in The European Lung White Book. Respiratory Health and Disease in Europe. Ch. 35. (European Lung Foundation, Sheffield, 2013)."},{"issue":"11","key":"266_CR5","first-page":"832","volume":"64","author":"CR Finley","year":"2018","unstructured":"Finley, C. R. et al. What are the most common conditions in primary care? Systematic review. Can. Fam. Physician 64(11), 832\u2013840 (2018).","journal-title":"Can. Fam. Physician"},{"key":"266_CR6","doi-asserted-by":"publisher","unstructured":"Pinnock, H. et al. The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010. Prim. Care Respir. J. https:\/\/doi.org\/10.4104\/pcrj.2010.00021 (2010).","DOI":"10.4104\/pcrj.2010.00021"},{"key":"266_CR7","doi-asserted-by":"publisher","unstructured":"Yoshida, S. Approaches, tools and methods used for setting priorities in health research in the 21st century. J. Glob. Health https:\/\/doi.org\/10.7189\/jogh.06.010507 (2016).","DOI":"10.7189\/jogh.06.010507"},{"key":"266_CR8","doi-asserted-by":"publisher","unstructured":"Bousquet, J. et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Euro. Respir. J. https:\/\/doi.org\/10.1183\/09031936.00012610 (2010).","DOI":"10.1183\/09031936.00012610"},{"key":"266_CR9","doi-asserted-by":"publisher","unstructured":"Vardavas, C. I. et al. H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases. Euro. Respir. J. https:\/\/doi.org\/10.1183\/13993003.01417-2019 (2019).","DOI":"10.1183\/13993003.01417-2019"},{"key":"266_CR10","doi-asserted-by":"publisher","unstructured":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2 (2020).","DOI":"10.1016\/S0140-6736(20)30752-2"},{"key":"266_CR11","doi-asserted-by":"publisher","unstructured":"Williams, S. et al. Respiratory research funding is inadequate, inequitable, and a missed opportunity. Lancet Respir. Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30329-5 (2020).","DOI":"10.1016\/S2213-2600(20)30329-5"},{"key":"266_CR12","unstructured":"IPCRG. Desktop helper 11 Remote consultations https:\/\/www.ipcrg.org\/dth11https:\/\/www.ipcrg.org\/aboutus (2021)."},{"key":"266_CR13","unstructured":"World Bank Data Team. New country classifications by income level: 2018\u20132019. (The World Bank Group, 2018)."},{"key":"266_CR14","doi-asserted-by":"publisher","unstructured":"Pinnock, H. et al. Prioritising the respiratory research needs of primary care: the international primary care respiratory group (IPCRG) e-Delphi exercise. Prim. Care Respir. J. https:\/\/doi.org\/10.4104\/pcrj.2012.00006 (2012).","DOI":"10.4104\/pcrj.2012.00006"},{"key":"266_CR15","doi-asserted-by":"publisher","unstructured":"Sumsion, T. The Delphi technique: an adaptive research tool. Br. J. Occup. Ther. https:\/\/doi.org\/10.1177\/030802269806100403 (1998).","DOI":"10.1177\/030802269806100403"},{"key":"266_CR16","doi-asserted-by":"publisher","unstructured":"Hsu, C. & Sandford, B. The Delphi technique: making sense of consensus. Pract. Assessment, Res. Eval. https:\/\/doi.org\/10.1016\/S0169-2070(99)00018-7 (2007).","DOI":"10.1016\/S0169-2070(99)00018-7"},{"key":"266_CR17","unstructured":"Online Surveys. Jisc online survey tool. https:\/\/www.onlinesurveys.ac.uk\/ (2020)."},{"key":"266_CR18","doi-asserted-by":"publisher","unstructured":"Soriano, J. B. et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir. Med. https:\/\/doi.org\/10.1016\/S2213-2600(17)30293-X (2017).","DOI":"10.1016\/S2213-2600(17)30293-X"},{"key":"266_CR19","unstructured":"Institute for Health Metrics and Evauation. Global Burden of Disease Compare. (University of Washington, 2019)."},{"key":"266_CR20","doi-asserted-by":"publisher","unstructured":"Ara\u00fajo, V., Teixeira, P. M., Yaphe, J. & Correia De Sousa, J. The respiratory research agenda in primary care in Portugal: a Delphi study. BMC Fam. Pract. https:\/\/doi.org\/10.1186\/s12875-016-0512-1 (2016).","DOI":"10.1186\/s12875-016-0512-1"},{"key":"266_CR21","doi-asserted-by":"publisher","unstructured":"Masefield, S. et al. The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP). Euro. Respir. J. https:\/\/doi.org\/10.1183\/13993003.02295-2016 (2017).","DOI":"10.1183\/13993003.02295-2016"},{"key":"266_CR22","doi-asserted-by":"publisher","unstructured":"Rudan, I. et al. Setting research priorities for global respiratory medicine within the national institute for health research (NIHR) global health research unit in respiratory health (RESPIRE). J. Glob. Health https:\/\/doi.org\/10.7189\/jogh.08.020314 (2018).","DOI":"10.7189\/jogh.08.020314"},{"key":"266_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.05.021","author":"RJ Stephens","year":"2015","unstructured":"Stephens, R. J. et al. Research priorities in mesothelioma: a James Lind Alliance Priority Setting Partnership. Lung Cancer https:\/\/doi.org\/10.1016\/j.lungcan.2015.05.021 (2015).","journal-title":"Lung Cancer"},{"key":"266_CR24","unstructured":"NIHR. James Lind Alliance. https:\/\/www.jla.nihr.ac.uk\/ (2020)."},{"key":"266_CR25","doi-asserted-by":"publisher","unstructured":"Hone, T., Macinko, J. & Millett, C. Revisiting Alma-Ata: what is the role of primary health care in achieving the Sustainable Development Goals? Lancet https:\/\/doi.org\/10.1016\/S0140-6736(18)31829-4 (2018).","DOI":"10.1016\/S0140-6736(18)31829-4"},{"key":"266_CR26","doi-asserted-by":"publisher","unstructured":"Ghebreyesus, T. A. How could health care be anything other than high quality? Lancet Glob. Health https:\/\/doi.org\/10.1016\/S2214-109X(18)30394-2 (2018).","DOI":"10.1016\/S2214-109X(18)30394-2"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-021-00266-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-021-00266-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-021-00266-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:32:21Z","timestamp":1669300341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-021-00266-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1038\/s41533-021-00266-4","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"13 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.A. holds grants related to respiratory epidemiology from the NIHR. She chairs the NIHR Public Health Research Funding Committee. Jv.B. has received consultancy fees, honorarium and research funding from AstraZeneca, Boehringer Ingelheim, Chiesi, Menarini, Novartis, Nutricia, Pill Connect, Teva and Trudell Medical to consult, give lectures, provide advice and conduct independent research, all paid to his institution. J.C.S. has in the last 3 years received payment for participating in educational activities from Boheringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis and Mundipharma. R.J. reports grants from the NIHR and participation in a Boehringer Ingelheim primary care advisory board during this project. J.K. reports grants, personal fees and non-financial support from AstraZeneca, grants, personal fees and non-financial support from Boehringer Ingelheim, grants and personal fees from Chiesi Pharmaceuticals, grants, personal fees and non-financial support from GSK, grants and personal fees from Novartis, grants from MundiPharma, grants from TEVA, outside the submitted work, all paid to his institution; and J.K. holds 72.5% of shares in the General Practitioners Research Institute. K.L. has received personal fees for lectures and educational activities from AstraZeneca, Novartis, Boehringer Ingelheim and Chiesi and served on advisory boards arranged by AstraZeneca, GlaxoSmithKline, Novartis and Boehringer Ingelheim. L.M. has received payment for participating in educational activities, consultancy, or support to attend clinical meetings from Hero Espa\u00f1a, Merck-Allergopharma, ALK-Abell\u00f3, Laboratorios Jofre-Roig, Laboratorios Leti, Faes Farma, Novartis, Inmunotek, GSK, and Alter. D.P. has board membership with Amgen, AstraZeneca, Boehringer Ingelheim, Chiesi, Circassia, Mylan, Mundipharma, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, Teva Pharmaceuticals, Thermofisher; consultancy agreements with Amgen, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Mylan, Mundipharma, Novartis, Pfizer, Teva Pharmaceuticals, Theravance; grants and unrestricted funding for investigator-initiated studies (conducted through Observational and Pragmatic Research Institute Pte Ltd) from AstraZeneca, Boehringer Ingelheim, Chiesi, Circassia, Mylan, Mundipharma, Novartis, Pfizer, Regeneron Pharmaceuticals, Respiratory Effectiveness Group, Sanofi Genzyme, Teva Pharmaceuticals, Theravance, UK National Health Service; payment for lectures\/speaking engagements from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline, Kyorin, Mylan, Mundipharma, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, Teva Pharmaceuticals; payment for the development of educational materials from Mundipharma, Novartis; payment for travel\/accommodation\/meeting expenses from AstraZeneca, Boehringer Ingelheim, Mundipharma, Mylan, Novartis, Thermofisher; funding for patient enrolment or completion of research from Novartis; stock\/stock options from AKL Research and Development Ltd which produces phytopharmaceuticals; owns 74% of the social enterprise Optimum Patient Care Ltd (Australia and UK) and 74% of Observational and Pragmatic Research Institute Pte Ltd (Singapore); 5% shareholding in Timestamp which develops adherence monitoring technology; is peer reviewer for grant committees of the Efficacy and Mechanism Evaluation programme, and Health Technology Assessment; and was an expert witness for GlaxoSmithKline. H.P. in the last 3 years was paid by Teva to write a piece on supported self-management for their website. Organisations with which she is involved, or conferences\/meetings at which she has spoken receive multi-company sponsorship. D.R. has in the last 3 years received payment for participating in educational activities, consultancy or support to attend clinical meetings from: AZ,BI, GSK, Chiesi, Novartis, Trudell, Meda, Regeneron and Medscape. He is a board member of the Primary care and allied health section of the European Academy of Allergy and clinical Immunology and vice president of the Respiratory Effectiveness Group. B.S. has received honoraria for educational activities and lectures from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, MEDA and TEVA and has served on advisory boards arranged by AstraZeneca, Novartis, GlaxoSmithKline, Boehringer Ingelheim and MEDA. S.S. has served as a consultant for Boehringer Ingelheim, Genentech, GlaxoSmithKline, AstraZeneca, Propeller Health, Sanofi, and Regeneron; and received a grant from Propeller Health. All payments were made to his university. A.T. has grants for respiratory research from AstraZeneca, Chiesi and CSL Behring, and has additional consultancy or honoraria for educational work for GSK and Boehringer Ingelheim. S.T. holds grants related to COPD and asthma from the NIHR. I.T. has in the last 3 years received payment for participating in educational activities, consultancy or received grants from: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis and ELPEN. She is the Editor in Chief of the npjPCRM. O.Y. holds a grant related to respiratory health from the NIHR. A.B., R.A., A.A.A., D.A., I.B., N.C., A.D., M.E., Fv.G., S.H., A.K., B.K., D.K., E.M., C.Mc., C.N., S.P., S.J.S., D.W., S.W. and A.K.T. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}